The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10969 malaria professionals are enjoying the free benefits of MalariaWorld today


Guilt by association: GM Mosquito = Monsanto Profits

September 26, 2010 - 23:16 -- Mark Benedict

Researchers who have been devoting themselves to creation of mosquitoes that cannot transmit disease are facing formidable foes: a warm reception for specious arguments and deep pocket anti-GM organizations.Plans to release GM mosquitoes in Malaysia provide a window into the opposition. Will GM mosquitoes be given a chance to improve human health?

Open Access | Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

September 2, 2010 - 12:01 -- Kabogo Ndegwa
Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, Njunju E, Gomes M, Ribeiro I, Walter V, Virtanen M, Schlienger R, Cousin M, Chipimo M, Sullivan FM
Malaria Journal 2010, 9:249 (1 September 2010)

These data suggest that exposure to AL in pregnancy, including first trimester, is not associated with particular safety risks in terms of perinatal mortality, malformations, or developmental impairment. However, more data are required on AL use during the first trimester.

Medical Treatment: 

Molecular identification and phylogeny of Myzomyia and Neocellia series of Anopheles subgenus Cellia (Diptera: Culicidae)

September 1, 2010 - 13:55 -- Patrick Sampao
Sunita Swain, Amitav Mohanty, H.K. Tripathy, Namita Mahapatra, Santanu K. Kar, Rupenangshu K. Hazra
Infection, Genetics and Evolution, Volume 10, Issue 7, October 2010, Pages 931-939

This assay can be applied as an unbiased confirmatory method for the identification of morphological variants, imperfectly preserved specimens and life stages for which taxonomic keys do not allow a definitive species determination.

Mosquito monitoring in the Subarctic

August 18, 2010 - 16:39 -- Lena Hulden

This season I have together with my husband been monitoring bloodsucking insects at the reindeer research station in Kaamanen, Lapland Finland (69˚ N lat.). The station is about 150 km from Barents Sea and the snow smelts in late May. The ground is frozen from October/November until May/June and the depth of the frost is 80 cm. The staff at the station is really friendly and helpful.

Curriculum vitae

June 23, 2010 - 12:22 -- Mohammed Sallam

·Demonstrator in the department of Entomology, Faculty of Science, Ain Shams University, 2002- present.
·Junior researcher in research and training center, WHO collaborating center, Faculty of Science building, Ain Shams University, 2002- 2007.
·M.Sc. on vector control of filarial vector Culex pipiens L. 2008.
·Assoc. Lecturer at Faculty of science, Ain Shams University, Abbaisa, Cairo, Egypt 2008 - Now
·PhD student at Food Sciences and Agricultural College, KSU, KSA 2009 – Now

Why mosquitoes?

June 19, 2010 - 12:58 -- William Jobin

Some of us are Seekers who ask “How? We are called Scientists. Some of us are Seekers who ask “Why?” We are called Believers. Some of us are both.

The boy and the old man sat in the shade of their favorite Neem tree during the oppressive heat of the afternoon. “Uncle, why did the Creator make mosquitoes that swarm around our heads and spread fevers?” asked the boy.

Development of Resistance to ACTs - Its a matter of time...

April 26, 2010 - 07:39 -- Patrick Sawa

The intelligence of a species like the protozoan we call Plasmodia is amazing. I have followed the response of patients to ACTs since their introduction a few years ago...The parasite clearance and symptomatic relief seems to be getting more sluggish with time.

IVCC and Syngenta reach key milestone in development of new insecticide for malaria mosquito control

April 23, 2010 - 09:22 -- Mark Birchmore

IVCC and Syngenta reach key milestone in development of new insecticide for malaria mosquito control.

• Field trials show Actellic® 300CS can provide at least 8 months control of pyrethroid resistant mosquitoes
• Actellic® 300CS micro-encapsulated formulation submitted to WHOPES
• Major step forward in development of new products for malaria control

Open Access | Duration of Protection Against Clinical Malaria Provided by Three Regimens of Intermittent Preventive Treatment in Tanzanian Infants

March 12, 2010 - 14:58 -- Ingeborg van Schayk
Matthew Cairns, Roly Gosling, Ilona Carneiro, Samwel Gesase, Jacklin F. Mosha, Ramadhan Hashim, Harparkash Kaur, Martha Lemnge, Frank W. Mosha, Brian Greenwood, Daniel Chandramohan
PLoS ONE 5(3): e9467

Intermittent preventive treatment in infants (IPTi) is a new malaria control tool. This study investigated how protection against malaria given by SP, chlorproguanil-dapsone (CD) and mefloquine (MQ), varied with time since administration of IPTi.

Medical Condition: 


Subscribe to RSS - Technology